跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISPERDAL CONSTA risperidone 25mg powder for injection vial with diluent syringe - TGA Drug Approval Details
Approvals
/
TGA
/
RISPERDAL CONSTA risperidone 25mg powder for injection vial with diluent syringe
Approved
STANDARD
RISPERDAL CONSTA risperidone 25mg powder for injection vial with diluent syringe
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2dcdf9eff2a7660c
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
2dcdf9eff2a7660c
Product Name
RISPERDAL CONSTA risperidone 25mg powder for injection vial with diluent syringe
Artg Id
81489
Artg Name
RISPERDAL CONSTA risperidone 25mg powder for injection vial with diluent syringe
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2003-04-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/512d249ce871e302a00b3dc7ac7e449e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8b272d77e371fd9af03ddf6e4560bcdc.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2dcdf9eff2a7660c
Type
Standard
Back to TGA Approvals